Comparing Montelukast vs Omalizumab
| Montelukast | Omalizumab |
|
|---|
| Montelukast | Omalizumab |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Montelukast is an oral medication that is usually taken daily for the maintenance treatment of asthma or allergic rhinitis. It will not relieve an acute asthma attack and some people may experience... View more |
Prescription only
Prescribed for Urticaria, Chronic Rhinosinusitis With Nasal Polyps, Nasal Polyps, Asthma - Maintenance, Food Allergies, Asthma. Omalizumab may also be used for purposes not listed in this medication guide. View more |
Related suggestions Asthma, Maintenance
Popular comparisons
|
|||||||
| More about Montelukast | More about Omalizumab | ||||||||
| Ratings & Reviews | |||||||||
|
Montelukast has an average rating of 5.6 out of 10 from a total of 575 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 41% reported a negative effect. |
Omalizumab has an average rating of 7.6 out of 10 from a total of 271 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Montelukast side effects |
View all Omalizumab side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Montelukast prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Singulair | Omlyclo, Xolair | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
5.5 hours |
624 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 119 drugs are known to interact with Montelukast:
|
A total of 33 drugs are known to interact with Omalizumab:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.